Haemonetics Corporation: operating_income
| Value | {"amount": 156033000, "concept": "us-gaap:OperatingIncomeLoss", "currency": "USD"} |
|---|---|
| Period | 2022-04-03 – 2023-04-01 |
| Status | current |
| Entity | Haemonetics Corporation |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T07:27:22.274537+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/581a6de0-9095-4dcd-894f-5a6656538a83
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0000313143-23-000014Retrieved: 2026-08-19T07:27:22.274537+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0000313143/operating-income/2023-04-01 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/581a6de0-9095-4dcd-894f-5a6656538a83
History
- no predecessors — first report